Answers are grounded in this paper and cite their sources.
The invention in this patent application relates to compounds having structures represented generally herein by formula 1. These compounds are modulators of alpha 4 beta 7 integrin and may provide useful treatment for several inflammatory conditions such as inflammatory bowel diseases, including ulcerative colitis and Crohn's disease.
No takes yet. Share an insight, caveat, or question.
Ahmed F. Abdel‐Magid (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: